☰ Navigation Tabs
Dimeric form of the trans-stabilized Hemolysin II C-terminal domain
NMR Experiment Experiment Type Sample Contents Solvent Ionic Strength pH Pressure Temperature (K) Spectrometer 1 2D 1H-15N HSQC 0.8 mM [U-99% 13C; U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 0.05 % w/v sodium azide, 1 mM AEBSF protease inhibitor 90% H2O/10% D2O 0 M 6.5 1 atm 303.15 Varian INOVA 600 2 3D HNCACB 0.8 mM [U-99% 13C; U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 0.05 % w/v sodium azide, 1 mM AEBSF protease inhibitor 90% H2O/10% D2O 0 M 6.5 1 atm 303.15 Varian INOVA 600 3 3D HNCO 0.8 mM [U-99% 13C; U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 0.05 % w/v sodium azide, 1 mM AEBSF protease inhibitor 90% H2O/10% D2O 0 M 6.5 1 atm 303.15 Varian INOVA 600 4 3D 1H-15N NOESY 0.8 mM [U-99% 13C; U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 0.05 % w/v sodium azide, 1 mM AEBSF protease inhibitor 90% H2O/10% D2O 0 M 6.5 1 atm 303.15 Varian INOVA 600 5 3D 1H-15N TOCSY 0.8 mM [U-99% 13C; U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 0.05 % w/v sodium azide, 1 mM AEBSF protease inhibitor 90% H2O/10% D2O 0 M 6.5 1 atm 303.15 Varian INOVA 600 6 3D 1H-13C NOESY (edited) 0.8 mM [U-99% 13C; U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 0.05 % w/v sodium azide, 1 mM AEBSF protease inhibitor 90% H2O/10% D2O 0 M 6.5 1 atm 303.15 Varian INOVA 600 7 3D 1H-13C NOESY (filtered) 0.8 mM [U-99% 13C; U-99% 15N] HlyIIC, 20 mM sodium phosphate, 1 mM EDTA, 0.05 % w/v sodium azide, 1 mM AEBSF protease inhibitor 90% H2O/10% D2O 0 M 6.5 1 atm 303.15 Varian INOVA 600
NMR Spectrometer Information Spectrometer Manufacturer Model Field Strength 1 Varian INOVA 600
NMR Refinement Method Details Software simulated annealing X-PLOR NIH
NMR Ensemble Information Conformer Selection Criteria structures with the least restraint violations Conformers Calculated Total Number 100 Conformers Submitted Total Number 25 Representative Model 1 (closest to the average)
Computation: NMR Software # Classification Version Software Name Author 1 chemical shift assignment CcpNmr Analysis 2.4 CCPN 2 data analysis CcpNmr Analysis 2.4 CCPN 3 geometry optimization TALOS TALOS-N Cornilescu, Delaglio and Bax 4 peak picking CcpNmr Analysis 2.4 CCPN 5 processing NMRPipe Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax 6 processing NMRDraw Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax 7 structure calculation X-PLOR NIH Schwieters, Kuszewski, Tjandra and Clore 8 refinement X-PLOR NIH Schwieters, Kuszewski, Tjandra and Clore